>
Switch to:

Turning Point Therapeutics Debt-to-Asset

: 0.00 As of Mar. 2021
View and export this data going back to 2019. Start your Free Trial

Turning Point Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2021 was $1.44 Mil. Turning Point Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2021 was $2.05 Mil. Turning Point Therapeutics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2021 was $1,127.58 Mil. Turning Point Therapeutics's debt to asset for the quarter that ended in Mar. 2021 was 0.00.


Turning Point Therapeutics Debt-to-Asset Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Turning Point Therapeutics Annual Data
Dec17 Dec18 Dec19 Dec20
Debt-to-Asset - - - -

Turning Point Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.01 - -

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Turning Point Therapeutics Debt-to-Asset Distribution

* The bar in red indicates where Turning Point Therapeutics's Debt-to-Asset falls into.



Turning Point Therapeutics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Turning Point Therapeutics's Debt-to-Asset for the fiscal year that ended in Dec. 2020 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.396 + 2.423) / 1136.713
=0.00

Turning Point Therapeutics's Debt-to-Asset for the quarter that ended in Mar. 2021 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.439 + 2.048) / 1127.584
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Turning Point Therapeutics  (NAS:TPTX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Turning Point Therapeutics Debt-to-Asset Related Terms


Turning Point Therapeutics Debt-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)